Allworth Financial LP Theravance Biopharma, Inc. Transaction History

Allworth Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$8.58 - $11.4 $1,415 - $1,881	165 Added 1269.23%	178 $2,000
Q3 2023 Oct 31, 2023	SELL	$8.38 - $10.44 $779 - $970	-93 Reduced 87.74%	13 $0
Q1 2023 Apr 18, 2023	BUY	$9.87 - $11.44 $1,046 - $1,212	106 New	106 $1,000
Q2 2022 Jul 13, 2022	SELL	$8.41 - $10.34 $9,503 - $11,684	-1,130 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$7.42 - $11.05 $8,384 - $12,486	1,130 New	1,130 $12,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.